Caliper Life Sciences' Third Quarter 2009 Financial Results Conference Call Notice

MONDAY, November 9, 2009 - 9:00 a.m. ET

• Press Release
• Source: Caliper Life Sciences, Inc.
• On 3:52 pm EDT, Tuesday October 20, 2009

HOPKINTON, Mass., Oct. 20 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP - News) will conduct a conference call discussing the company's third quarter 2009 financial results at 9:00 a.m. ET on Monday, November 9. Kevin Hrusovsky, President and Chief Executive Officer and Peter McAree, Chief Financial Officer, will host the call. Management will discuss operational and financial results and the company's outlook for the future.

A news release discussing Caliper's third quarter 2009 financial results will be issued Monday, November 9 at approximately 7:00 a.m. ET.

Participants please call 888.713.4209 five to ten minutes prior to the call and use the participant passcode of 32507029. International callers can access the call by dialing 617.213.4863 and entering the same passcode. You may also pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=PKV9RF3HB.

A live webcast of the call can be accessed at www.fulldisclosure.com or on the Caliper website at www.caliperLS.com in the Events section of the Investor Relations page. A webcast replay of the call will remain available until Caliper's earnings call for the fourth quarter of 2009.

Telephone replays of the conference call will be available approximately two hours after the completion of the call. To access a telephone playback of the proceedings from November 9 through November 16, dial 888-286-8010 and use the participant passcode of 93641840. International callers can access the playback by dialing 617-801-6888 and using the same participant passcode.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.

Buzz up!